An inhibition immunoassay method for the determination of pyridinoline was developed with the use of microtitre plates coated with a pyridinoline-gelatin conjugate and rabbit antisera directed against pyridinoline linked to bovine serum albumin. The sensitivity of the assay is about 2 pmol of pyridinoline, and the presence of related pyridinium and lysine-derived compounds does not significantly interfere with the procedure. Its application to tissue and human urine samples is described.
Pyridinoline is a 3-hydroxypyridinium compound derived from hydroxylysine (Fujimoto et al., 1977 (Fujimoto et al., . 1978 ) that is present primarily in bone, cartilage and tendon, but also in those tissues where hydroxylation of telopeptide lysine residues is extensive, such as scar tissue (Moriguchi & Fujimoto, 1979) . This compound has been proposed as a trifunctional cross-link in mature collagen (Fujimoto, 1980) .
The present paper describes a sensitive immunoassay method for the determination of pyridinoline that was developed to facilitate analysis of the distribution and changes with age in the amounts of this component in small tissue samples. The procedure also provides a unique index of the degradation of certain forms of mature collagen by analysis of physiological fluids, and its application to the analysis of human urine is described.
Experimental and results Materials
Polyoxyethylene sorbitol monolaurate (Tween 20), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, pig skin gelatin and alkaline phosphatase coupled to goat anti-rabbit antibodies, together with the enzyme substrate p-nitrophenyl phosphate (Sigma 104), were obtained from Sigma Chemical Co., Poole, Dorset, U.K. Polystyrene 96-well microtitre plates (flat-bottomed) were from Flow Laboratories, Irvine, Ayrshire, Scotland, U.K., and sodium cyanoborohydride was obtained from Aldrich Chemical Co., Gillingham, Dorset, U.K.
Isolation ofcross-link compounds
Pyridinoline was isolated from decalcified longbones of 1 1-year-old sheep by ion-exchange chromatography with 67mM-sodium citrate buffers on sulphonated cross-linked polystyrene resins maintained at 600C. Final purification was achieved by Vol. 207 chromatography with pH 4.25 buffer (Robins, 1982) , and the sample was desalted by using a column (1.6 cm x 90 cm) of Bio-Gel P-2 with 0.1 Macetic acid as eluent. The structure of the compound proposed by Fujimoto et al. (1978) was confirmed by 14C n.m.r. and fast-atom-bombardment mass spectrometry (S. P. Robins, unpublished work). Desmosine, isodesmosine, merodesmosine and lysinonorleucine were isolated from bovine ligamentum nuchae, and reduced lysine-derived components were isolated from borohydride-treated Achilles-tendon collagen as described previously (Robins, 1982) .
Preparation ofanti-pyridinoline sera The antigen was prepared by linking pyridinoline to bovine serum albumin. To a solution of the protein (10mg) in water (0.7ml) was added 1-(3 -dimethylaminopropyl) -3 -ethylcarbodi -imide (100mg) followed by an aqueous solution (0.3 ml) of pyridinoline (4.5 mg). After reaction for 3 h at room temperature, the solution was dialysed against six changes (lOOml) of distilled water and freeze-dried. Amino acid analysis and fluorescence measurements showed that the product contained 9.5 mol of pyridinoline/mol of albumin.
The pyridinoline-albumin conjugate was dissolved in phosphate-buffered saline (0.14 M-NaCl/ 10mM-sodium phosphate buffer, pH 7.4), emulsified with an equal volume of Freund's complete adjuvant and then injected intradermally at multiple sites into New Zealand White rabbits. Each animal received about 1 50,ug of antigen in this and in subsequent booster injections given with Freund's incomplete adjuvant at monthly intervals. Useful titres were obtained after 4-5 months.
Preparation ofcoating proteinfor immunoassay
Pyridinoline covalently linked to gelatin was used 0306-3275/82/120617-04$01.50/1 (© 1982 The Biochemical Society to coat the microtitre plates for the assay, as gelatin and the albumin used as antigen were judged to have no common antigenic determinants. Preliminary experiments with material in which pyridinoline was linked to gelatin by the carbodi-imide method showed, however, that the rabbit sera contained antibodies directed against the carbodi-imide adduct. Thus positive reactions with the antisera were obtained with the carbodi-imide-treated gelatin alone, in the absence of pyridinoline.
As an alternative method for linking pyridinoline to gelatin, periodate oxidation of the hydroxylysine residues followed by a reductive amination reaction was performed (Scheme 1). Gelatin (10mg) in 3ml of 0.1 M-sodium phosphate buffer, pH 4.4, was treated with aqueous NaIO4 (final concn. 0.1 M) in the dark for 1 h. The solution was dialysed for a total of 5 h against four changes (100ml) of 50mM-sodium phosphate buffer, pH7.5, and the oxidized gelatin solution was then added to pyridinoline (6mg), followed by the addition of solid NaBH3CN (20 mg). The reaction was left to continue at room temperature for 24 h, after which time acetic acid was added to pH 4 to allow reduction of any unmodified aldehyde groups. The product was dialysed against water and freeze-dried. The conjugated protein contained 50nmol of pyridinoline/mg of gelatin, as determined by amino acid analysis.
Pyridinoline immunoassay
On the basis of a series of experiments with various dilutions of coating protein and antisera, an inhibition assay under non-equilibrium conditions was developed as shown in Fig. 1 . The samples were preincubated with a constant amount of anti-pyridinoline serum, and the decrease in activity was detected by an enzyme-linked immunosorbent assay (Engvall & Perlmann, 1972) with microtitre plates coated with pyridinoline-gelatin. The plates were coated for 18h at room temperature and, where necessary, were stored at 40 C after being sealed with tape. All washings of the plates were performed three times with 0.05% Tween 20 in phosphate-buffered saline.
Possible interference by other amino acids and compounds whose structure was related to that of pyridinoline were tested in the standard assay Pyridinoline (pmol) Fig. 1 . Inhibition immunoassayforpyridinoline Microtitre plates were coated with pyridinoline gelatin in phosphate-buffered saline (0.6,g/ml). TI samples (0.12ml) in phosphate-buffered saline wer preincubated for 30 min in a separate microtitr plate with 0.12ml of antiserum diluted with 0.1c
Tween 20 in phosphate-buffered saline (final dilutio 1:200). Samples were transferred to the washe coated plate and left to react for I h. After the plat had been washed, 0.2 ml of goat anti-rabbit ant bodies linked to alkaline phosphatase (1:100 dilution in 0.05% Tween 20 in phosphate-buffere saline) was added, and 1 h later the plate was agai washed followed by the addition of 0.2ml of solution of enzyme substrate (1mg/ml) in 5OmN sodium carbonate buffer, pH9.6, containing 1mrv CaCl2. The reaction was stopped after 30min b adding 2M-NaOH (O.1ml), and the absorbance e 405nm in each well was measured directly with Titertek Multiskan instrument (Flow Laboratories The results are expressed as percentages of a max mum value determined in the same microtitre plal by using phosphate-buffered saline alone at the pre incubation step. The concentration of pyridinoline in the urine of a control group of eight individuals aged between 30 and 45 years was 0.85 + 0.17 nmol/mg of creatinine. Addition of pyridinoline to a hydrolysed urine sample at 0.1 nmol/ml was detected with a coefficient of variation of 8%. Preliminary analyses of patients (aged between 57 and 82 years) with osteoarthritis have indicated a much higher urinary pyridinoline excretion at 3.91 +0.84nmol/mg of creatinine (n = 6), and in a patient (aged 74 years) with Paget's disease of bone the urinary concentration of pyridinoline was 10.1 nmol/mg of creatinine. These differences in pyridinoline excretion do not appear to be merely due to the age differences, although a systematic investigation of the variations with age is not yet complete.
Discussion
The technique described provides a rapid, sensitive and highly specific assay for pyridinoline. The attachment of the molecule to a solid support for the enzyme-linked assay has some advantages over radioimmunoassay methods that have been developed for desmosine (King et al., 1980; Harel et al., 1980) in that the separation of bound and unbound antibody is simplified. The gelatin used for preparing the coating protein contained no pyridinoline, although its presence would not have affected the assay, as the antibodies recognize only free pyridinoline and not its peptide-bound form. The 'active' pyridinoline in the coating protein is attached to oxidized hydroxylysine itself and not to any carbohydrate moiety, as linking of pyridinoline to the glycoprotein mucin produced a conjugate that was unreactive towards the antisera, despite containing a much higher proportion of bound pyridinoline than the gelatin. The reason for this is unclear, but it may reflect masking of the antigenic determinant through reaction of two amino groups of the molecule with the dialdehyde oxidation products of the carbohydrate.
The presence in human urine of a 3-hydroxypyridinium compound with chromatographic and fluorescence properties identical with those of. pyridinoline was reported by Gunja-Smith & Boucek (1981) . The immunoassay method for pyridinoline, which does not require preliminary fractionation of the urine, provides a simpler and more-sensitive technique that is suitable for routine screening. The increased urinary excretion of this compound in patients with certain bone and joint disorders suggests that measurement of pyridinoline may indeed have some clinical applications in the management of these conditions.
